Legal status · United States
Is Oveporexton legal in the United States?
Written by Aaron CuhaReviewed Sep 2026
Direct answer
Yes. Oveporexton is an approved medicine in the United States, classified as "FDA-approved, prescription only". Approval covers its labeled indication and it is supplied on prescription, not over the counter. Products labeled "research use only" fall outside that approval and the label does not make human use lawful. On the evidence, 6 human studies are cited on its profile.
Oveporexton in the United States at a glance
| Classification | FDA-approved, prescription only |
|---|---|
| Note | Orzeyful, NDA 220860, approved 5 August 2026 for narcolepsy type 1 in adults; Drugs@FDA marketing status Prescription. Controlled substance schedule pending. |
| FDA approval status | FDA approved 5 August 2026 (Orzeyful, NDA 220860, orphan designation, priority review) for narcolepsy type 1 in adults. Controlled substance schedule pending DEA review at the time of labelling. |
| Human studies cited | 6 of 9 citations on the profile |
| Reviewed | Sep 2026 |
Classification and note come from the Oveporexton profile, checked against U.S. Food and Drug Administration (FDA) listings at the reviewed date.
What this means
- 01
FDA has approved Oveporexton for at least one labeled indication, so a pharmaceutical-grade product exists in the United States and is dispensed on prescription.
- 02
Approval is indication-specific. Uses outside the label are a clinical decision for a prescriber, not something the approval itself authorizes.
- 03
Unlicensed online vials, including those labeled "research use only", are not the approved product and are not covered by the approval.
What Oveporexton is
An oral orexin receptor 2 agonist, not a peptide, approved by the FDA on 5 August 2026 for narcolepsy type 1 in adults. In two 12 week phase 3 trials totalling 273 people it lengthened time awake on the Maintenance of Wakefulness Test by 14 to 20 minutes against roughly no change on placebo; a majority of treated participants developed insomnia and urinary frequency.
51 daltons, not a peptide. It is on this site because it is the first approved drug that acts at the receptor for orexin-A, the wake-promoting peptide whose neurons are lost in narcolepsy type 1.
Mechanism: In people with narcolepsy type 1 the hypothalamic neurons that make orexin-A and orexin-B are lost, so both orexin peptides are deficient while their receptors remain. Oveporexton is a selective agonist at orexin receptor 2 (OX2R), the receptor most tied to maintaining wakefulness, and it restores signalling at that receptor without replacing the peptide.
Regulatory history: FDA approved 5 August 2026 (Orzeyful, NDA 220860, orphan designation, priority review) for narcolepsy type 1 in adults. Controlled substance schedule pending DEA review at the time of labelling.
How FDA treats this kind of product
Approves prescription drugs by indication and polices unapproved products, including peptides sold online. Compounding pharmacies may prepare some compounds under a prescription when the FDA places them on a permitted bulk-substances category.
The classification above is the The Longevity Archive reading of U.S. Food and Drug Administration listings for Oveporexton at the reviewed date, not a legal opinion. Rules change, and importing, prescribing and possessing a compound can each be treated differently. Check the regulator directly before acting on anything here.
Oveporexton in other countries
Frequently asked questions
Is Oveporexton legal in the United States?
Yes. Oveporexton is an approved medicine in the United States, classified as "FDA-approved, prescription only". Approval covers its labeled indication and it is supplied on prescription, not over the counter. Products labeled "research use only" fall outside that approval and the label does not make human use lawful. On the evidence, 6 human studies are cited on its profile. Note: Orzeyful, NDA 220860, approved 5 August 2026 for narcolepsy type 1 in adults; Drugs@FDA marketing status Prescription. Controlled substance schedule pending.
Can I buy Oveporexton in the United States?
Only with a prescription. Oveporexton is classified as "FDA-approved, prescription only" in the United States, so it is dispensed by pharmacies against a prescription for its approved indication. Buying it from unlicensed online sellers or as a "research chemical" is outside that system and carries no regulatory protection. Note: Orzeyful, NDA 220860, approved 5 August 2026 for narcolepsy type 1 in adults; Drugs@FDA marketing status Prescription. Controlled substance schedule pending.
Is Oveporexton FDA approved?
Yes. FDA status: FDA approved 5 August 2026 (Orzeyful, NDA 220860, orphan designation, priority review) for narcolepsy type 1 in adults. Controlled substance schedule pending DEA review at the time of labelling.. Current US classification: "FDA-approved, prescription only". On the evidence, 6 human studies are cited on its profile.
Related compounds in the United States
Full research profile
Mechanism, cited studies, FDA status and the full legal summary for Oveporexton live on its compound profile.
Oveporexton profileThis page is general information about the regulatory status of Oveporexton in the United States, current as of Sep 2026. It is not legal advice, and classifications change; check U.S. Food and Drug Administration directly or consult a lawyer for a specific situation. Educational use only. This database summarizes published research. It is not medical advice and contains no dosing protocols or recommendations for personal use. The Longevity Archive has no vendor relationships and does not recommend where to buy anything.